Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000839787 | SCV000981694 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001554650 | SCV001775922 | benign | Developmental and epileptic encephalopathy, 42 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554651 | SCV001775923 | benign | Episodic ataxia type 2 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554652 | SCV001775924 | benign | Migraine, familial hemiplegic, 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554653 | SCV001775925 | benign | Spinocerebellar ataxia type 6 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594197 | SCV005087363 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 82% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 76. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000839787 | SCV005315292 | benign | not provided | criteria provided, single submitter | not provided |